Vomiting after intrathecal chemotherapy under anesthesia in pediatric patients with hematologic cancers: A cohort study

Author:

França de Moraes Gustavo Henrique1ORCID,Lima Luciana Cavalcanti23ORCID,Couceiro Tania Cursino de Menezes1,Lins Mecneide Mendes4ORCID,Cumino Débora de Oliveira5ORCID,Simões Leonardo Augusto Barbosa Magalhães3ORCID,Mello Maria Júlia Gonçalves de6ORCID

Affiliation:

1. Department of Anesthesiology Instituto de Medicina Integral Prof. Fernando Figueira Recife Brazil

2. Department of Pediatric Anesthesiology Instituto de Medicina Integral Prof. Fernando Figueira Recife Brazil

3. Faculdade Pernambucana de Saúde Recife Brazil

4. Pediatric Oncology Unit Instituto de Medicina Integral Prof. Fernando Figueira Recife Brazil

5. Department of Pediatric Anesthesiology Hospital Infantil Sabará São Paulo Brazil

6. Post Graduate and Research Department Instituto de Medicina Integral Prof. Fernando Figueira Recife Brazil

Abstract

AbstractIntroductionDespite preventive strategies, vomiting is an adverse event affecting patients with cancer. However, literature on the incidence and risk factors for vomiting in pediatric patients with cancer are scarce.AimTo assess the incidence and risk factors for vomiting within 24 h and goodness of fit for the Eberhart score in pediatric patients with hematologic cancers after receiving intrathecal chemotherapy under deep sedation.MethodsThis prospective cohort study included patients under 20 years of age with hematologic cancers who were scheduled to undergo intrathecal chemotherapy under anesthesia. The primary outcome was the occurrence of vomiting within 24 h after the end of anesthesia. Sociodemographic and procedure data and underlying diseases were collected. Patients were monitored during the procedure, in the postanesthesia care unit, and the day after (by phone call).ResultsA total of 139 patients were included, and the incidence of vomiting was 30.9% within 24 h after intrathecal chemotherapy under anesthesia, with 90.7% of vomiting prior to 6 h. Prophylactic ondansetron was administered prior to the procedure to 45.3% of patients. Risk factors for vomiting were female gender (hazard ratio: 2.47, 95% confidence interval: 1.35–4.53, p: .003), consolidation phase of treatment (hazard ratio: 2.16, 95% confidence interval: 1.10–4.24, p: .025), and history of kinetosis (hazard ratio: 2.49, 95% confidence interval: 1.31–4.70, p: .005). Incidence of vomit was higher than estimated by the Eberhart score distribution (observed incidence in patients with a score of zero: 33.3%; with a score of one: 28.8%; with a score of two: 60%).ConclusionA high incidence of vomiting was observed within 24 h after intrathecal chemotherapy under propofol deep sedation. Risk factors for this outcome were established (being female, consolidation phase of treatment, and previous kinetosis), and evidence suggested that the Eberhart score was not suitable for the studied population.

Publisher

Wiley

Subject

Anesthesiology and Pain Medicine,Pediatrics, Perinatology and Child Health

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3